Form 8-K - Current report:
SEC Accession No. 0001640334-25-001184
Filing Date
2025-07-11
Accepted
2025-07-11 16:36:40
Documents
59
Period of Report
2025-07-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8K artl_8k.htm   iXBRL 8-K 129260
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM artl_ex231.htm EX-23.1 2274
3 FINANCIALS artl_ex991.htm   iXBRL EX-99.1 468159
4 FINANCIALS artl_ex992.htm   iXBRL EX-99.2 362276
  Complete submission text file 0001640334-25-001184.txt   4684771

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA artl-20250711.xsd EX-101.SCH 39446
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE artl-20250711_lab.xml EX-101.LAB 244564
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE artl-20250711_cal.xml EX-101.CAL 37304
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE artl-20250711_pre.xml EX-101.PRE 208451
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE artl-20250711_def.xml EX-101.DEF 121526
65 EXTRACTED XBRL INSTANCE DOCUMENT artl_8k_htm.xml XML 937078
Mailing Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075 858-925-7049
ARTELO BIOSCIENCES, INC. (Filer) CIK: 0001621221 (see all company filings)

EIN.: 331220924 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38951 | Film No.: 251119383
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)